Wednesday, July 18, 2018
MZ Digital Marketing Agency
from Reuters: Health News https://ift.tt/2LdS0Ls
Wednesday, July 18, 2018
Wednesday, July 18, 2018
MZ Digital Marketing Agency
HEALTH NEWS
No comments
AbbVie Inc said on Tuesday it signed a U.S. licensing deal with Mylan NV for its proposed biosimilar to AbbVie's blockbuster drug Humira, in a move that will give it more near-term control over the competition.
from Reuters: Health News https://ift.tt/2LdS0Ls
from Reuters: Health News https://ift.tt/2LdS0Ls
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment